You have 9 free searches left this month | for more free features.

avelumab

Showing 1 - 25 of 171

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Avelumab in Real-World Treatment for Advanced or Metastatic

Not yet recruiting
  • Bladder Cancer
  • Avelumab
  • (no location specified)
Nov 21, 2022

Breast Cancer Trial (Avelumab, Aspirin, Lansoprazole)

Not yet recruiting
  • Breast Cancer
  • Avelumab
  • +2 more
  • (no location specified)
Feb 2, 2023

Advanced Urothelial Carcinoma Trial in Boston (copanlisib, Avelumab)

Not yet recruiting
  • Advanced Urothelial Carcinoma
  • Boston, Massachusetts
    VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain,
Jan 13, 2023

Japanese RCC Patients Treated With Avelumab Plus Axitinib as

Not yet recruiting
  • Renal Cell Carcinoma
  • (no location specified)
Jan 18, 2023

Lymphomas Non-Hodgkin's B-Cell Trial in Ballarat, Box Hill, Heidelberg (Avelumab)

Active, not recruiting
  • Lymphomas Non-Hodgkin's B-Cell
  • Avelumab
  • Ballarat, Victoria, Australia
  • +2 more
Jan 30, 2023

Breast Cancer Trial in Washington, Charlotte, Salt Lake City (Talazoparib, Avelumab)

Active, not recruiting
  • Breast Cancer
  • Washington, District of Columbia
  • +1 more
Oct 10, 2022

Urothelial Carcinoma Trial in Iowa City (Avelumab, Docetaxel)

Active, not recruiting
  • Urothelial Carcinoma
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Oct 18, 2022

Leptomeningeal Metastases, Leptomeningeal Disease Trial in Tampa (Avelumab, Whole Brain Radiotherapy)

Active, not recruiting
  • Leptomeningeal Metastases
  • Leptomeningeal Disease
  • Avelumab
  • Whole Brain Radiotherapy
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Aug 19, 2022

Meningioma, Meningioma, Adult Trial in Saint Louis (drug, radiation, procedure)

Active, not recruiting
  • Meningioma
  • Meningioma, Adult
  • Avelumab
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 27, 2022

Sarcoma, Advanced Sarcoma, High Grade Sarcoma Trial in New York (DCC-3014, Avelumab)

Active, not recruiting
  • Sarcoma
  • +6 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 26, 2022

Recurrent or Metastatic NPC Trial in Hong Kong (Axitinib, Avelumab)

Recruiting
  • Recurrent or Metastatic NPC
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Prince of Wales Hospital, The C
Jul 18, 2022

POLE Exonuclease Mutant Colon Cancer, Microsatellite Instability, Stage III Colon Cancer Trial in Sutton (Avelumab)

Terminated
  • POLE Exonuclease Mutant Colon Cancer
  • +2 more
  • Avelumab
  • Sutton, Surrey, United Kingdom
    Royal Marsden NHS Foundation Trust
Oct 5, 2022

Hepatocellular Carcinoma Trial in Dallas (Axitinib, Avelumab, Bavituximab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Dallas, Texas
    The University of Texas Southwestern Medical Center
Jun 27, 2022

Non Small Cell Lung Cancer, Solid Tumor Trial in Jette, Brussel (Avelumab, Ipilimumab 5 MG/ML, Pembrolizumab 100 MG in 4 ML

Recruiting
  • Non Small Cell Lung Cancer
  • Solid Tumor
  • Avelumab
  • +3 more
  • Jette, Brussels, Belgium
  • +1 more
Sep 9, 2022

Metastatic Colorectal Cancer, RAS Wild Type Trial in Napoli (Avelumab, Cetuximab)

Completed
  • Metastatic Colorectal Cancer
  • RAS Wild Type
  • Napoli, Italy
    Università della Campania Luigi Vanvitelli
May 4, 2022

Advanced Clear Cell Renal Cell Carcinoma Trial in Boston (Axitinib, Palbociclib, Avelumab)

Not yet recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • Boston, Massachusetts
  • +2 more
Jun 27, 2022

Head Neck Cancer, Squamous Cell Carcinoma Trial in London (Avelumab, Cetuximab)

Active, not recruiting
  • Head and Neck Cancer
  • Squamous Cell Carcinoma
  • London, United Kingdom
    University College Hospital
May 17, 2022

Osteosarcoma Trial in United States (Avelumab, Questionnaires)

Active, not recruiting
  • Osteosarcoma
  • Avelumab
  • Questionnaires
  • Los Angeles, California
  • +3 more
Aug 22, 2022

OBSERVATIONAL STUDY OF AVELUMAB AS FIRST-LINE MAINTENANCE

Recruiting
  • Urothelial Cancer
  • Avelumab
  • Bristol, United Kingdom
  • +9 more
Jan 23, 2023

Clear-Cell Renal Carcinoma Trial run by the NCI (rhIL-15, Avelumab)

Terminated
  • Clear-Cell Renal Carcinoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 27, 2022

Stage III Merkel Cell Carcinoma AJCC v8, Stage IIIB Merkel Cell Carcinoma AJCC v8, Stage IIIA Merkel Cell Carcinoma AJCC v8

Recruiting
  • Stage III Merkel Cell Carcinoma AJCC v8
  • +2 more
  • Avelumab
  • +2 more
  • Orange, California
  • +10 more
Jan 30, 2023

Treatment Related Cancer Trial in Munich (5-FU, Folinic Acid, Irinotecan)

Active, not recruiting
  • Treatment Related Cancer
  • Munich, Germany
    Ludwig Maximilians University
Jan 19, 2022

And Use Of Avelumab In Combination With Axitinib For Treatment

Recruiting
  • Advanced Renal Cell Carcinoma
  • Sandwich, Kent, United Kingdom
    Pfizer Ltd
May 23, 2022

SOGUG-AVELUMAB_RWD

Recruiting
  • Metastatic Urothelial Carcinoma
  • Avelumab
  • Vigo, Pontevedra, Spain
  • +21 more
Jan 17, 2023

Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Recurrent Breast Cancer Trial in London (Palbociclib, Avelumab)

Recruiting
  • Triple Negative Breast Cancer
  • +5 more
  • Manchester, Greater Manchester, United Kingdom
  • +6 more
Jan 5, 2023